99 related articles for article (PubMed ID: 18625756)
21. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
Lublin FD; Reingold SC
Ann Neurol; 2001 May; 49(5):677-81. PubMed ID: 11357961
[TBL] [Abstract][Full Text] [Related]
22. Treatments for pulmonary arterial hypertension.
Liu C; Liu K; Ji Z; Liu G
Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.
Fox BD; Shimony A; Langleben D
Am J Cardiol; 2011 Oct; 108(8):1177-82. PubMed ID: 21864815
[TBL] [Abstract][Full Text] [Related]
24. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
Hammad TA; Pinheiro SP; Neyarapally GA
Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
[TBL] [Abstract][Full Text] [Related]
25. Clinical trials in the new millennium.
DeMets DL
Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
[TBL] [Abstract][Full Text] [Related]
26. [International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)].
Pittrow D; Ghofrani HA; Opitz CF; Huscher D; Hoeper MM
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S173-5. PubMed ID: 19718609
[TBL] [Abstract][Full Text] [Related]
27. [Dana Point: what is new in the treatment of pulmonary hypertension?].
Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
[TBL] [Abstract][Full Text] [Related]
28. [Ethical problems in randomized clinical trials from the aspect of statistics. Part I. Is patient randomization acceptable from the ethical viewpoint?].
Haas T
Cas Lek Cesk; 2001 Jun; 140(11):335-42. PubMed ID: 11431853
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy in pulmonary arterial hypertension: a meta-analysis.
Bai Y; Sun L; Hu S; Wei Y
Cardiology; 2011; 120(3):157-65. PubMed ID: 22212696
[TBL] [Abstract][Full Text] [Related]
30. Ethical dilemmas encountered during clinical drug trials.
Daicos GK
Hum Health Care; 2001; 1(2):E9. PubMed ID: 14986633
[TBL] [Abstract][Full Text] [Related]
31. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
[TBL] [Abstract][Full Text] [Related]
32. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update.
Johnson SG; Kayser SR; Attridge RL; Duvall L; Kiser TH; Moote R; Reed BN; Rodgers JE; Erstad B
Pharmacotherapy; 2012 Jun; 32(6):e134-69. PubMed ID: 22467427
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of ethical conflicts associated with randomized, controlled trials in critically ill children.
Morris AD; Zaritsky AL; LeFever G
Crit Care Med; 2000 Apr; 28(4):1152-6. PubMed ID: 10809297
[TBL] [Abstract][Full Text] [Related]
34. Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.
Provencher S; Archer SL; Ramirez FD; Hibbert B; Paulin R; Boucherat O; Lacasse Y; Bonnet S
Circ Res; 2018 Mar; 122(7):1021-1032. PubMed ID: 29599278
[TBL] [Abstract][Full Text] [Related]
35. Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trials.
Halpern SD
Control Clin Trials; 2002 Jun; 23(3):274-88. PubMed ID: 12057879
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trials in children--ethical and methodological issues.
Henschel AD; Rothenberger LG; Boos J
Curr Pharm Des; 2010; 16(22):2407-15. PubMed ID: 20513232
[TBL] [Abstract][Full Text] [Related]
37. Stem cell trials for cardiovascular medicine: ethical rationale.
Niemansburg SL; Teraa M; Hesam H; van Delden JJ; Verhaar MC; Bredenoord AL
Tissue Eng Part A; 2014 Oct; 20(19-20):2567-74. PubMed ID: 24164351
[TBL] [Abstract][Full Text] [Related]
38. The withholding of test results as a means of assessing the effectiveness of treatment in test-positive persons.
Weiss NS
J Clin Epidemiol; 2013 Apr; 66(4):355-8. PubMed ID: 22981247
[TBL] [Abstract][Full Text] [Related]
39. Using numerical modeling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample.
Boissel JP; Pérol D; Décousus H; Klingmann I; Hommel M
PLoS One; 2021; 16(10):e0258093. PubMed ID: 34634062
[TBL] [Abstract][Full Text] [Related]
40. Ethics of randomized trials in pediatric surgery.
Rentea RM; Oyetunji TA; Peter SDS
Pediatr Surg Int; 2020 Aug; 36(8):865-867. PubMed ID: 32394059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
